APA (7th ed.) Citation

Castañeda-Estévez, E., Vergara-Dangond, C., Steiner, M., Paredes-Romero, M. B., Esteban-Vázquez, A., Cobo-Ibañez, T., . . . Muñoz-Fernández, S. (2025). Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors. Pharmaceuticals (Basel, Switzerland), 18(1), 22. https://doi.org/10.3390/ph18010022

Chicago Style (17th ed.) Citation

Castañeda-Estévez, Elisabet, et al. "Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors." Pharmaceuticals (Basel, Switzerland) 18, no. 1 (2025): 22. https://doi.org/10.3390/ph18010022.

MLA (9th ed.) Citation

Castañeda-Estévez, Elisabet, et al. "Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 1, 2025, p. 22, https://doi.org/10.3390/ph18010022.